Directory
>
Michael Boxer
Michael Boxer
VP Clinical Research and Ophthalmology | MeiraGTx
United States
Michael Boxer
Summary
Michael Boxer is a seasoned executive in the field of clinical research and ophthalmology, currently serving as the VP at MeiraGTx, a company at the forefront of gene therapy innovation. He has a robust background in clinical study design and medical monitoring, contributing significantly to the development of therapies for ocular diseases and neurodegenerative conditions. With extensive experience in leading clinical trials, Michael has a proven track record of advancing medical research and improving patient outcomes. Previously, he held the position of SVP Clinical Research at Kadmon, where he spearheaded initiatives in various therapeutic areas. His leadership skills are complemented by a deep understanding of the biopharmaceutical landscape, making him a valuable asset in any organization focused on transformative healthcare solutions. Michael is passionate about addressing unmet medical needs and is committed to pushing the boundaries of scientific research. He is recognized for his strategic vision and ability to foster collaboration among multidisciplinary teams.
Michael Boxer
Work Experience
VP Clinical Research and Ophthalmology at
MeiraGTx
June 2015 - Present
SVP Clinical Research Global Head of Ophthalmology at
Kadmon
April 2011 - May 2015
Frequently Asked Questions about Michael Boxer
What is Michael Boxer email address?
Michael Boxer's primary email address is *************@meiragtx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Michael Boxer work for?
Michael Boxer is a VP Clinical Research and Ophthalmology at MeiraGTx, a company specializing in Commercial physical research.
How can I directly contact Michael Boxer?
To contact Michael Boxer directly, you can use the email address *************@meiragtx.com. Complete contact information is available upon registration with Muraena.
Who is Michael Boxer?
Michael Boxer is a seasoned executive in the field of clinical research and ophthalmology, currently serving as the VP at MeiraGTx, a company at the forefront of gene therapy innovation. He has a robust background in clinical study design and medical monitoring, contributing significantly to the development of therapies for ocular diseases and neurodegenerative conditions. With extensive experience in leading clinical trials, Michael has a proven track record of advancing medical research and improving patient outcomes. Previously, he held the position of SVP Clinical Research at Kadmon, where he spearheaded initiatives in various therapeutic areas. His leadership skills are complemented by a deep understanding of the biopharmaceutical landscape, making him a valuable asset in any organization focused on transformative healthcare solutions. Michael is passionate about addressing unmet medical needs and is committed to pushing the boundaries of scientific research. He is recognized for his strategic vision and ability to foster collaboration among multidisciplinary teams.
Michael`s contact details
*************@meiragtx.com
Colleagues
Vice President Preclinical Development
VP MSAT
Chief Operating Officer
Chief Medical Officer
Vice President, Salivary Gland Therapeutics Lead
Executive Director, CMC Regulatory Affairs
Chief Executive Officer
VP, Biostatistics
Senior Vice President, Head of Business Development